Technical Analysis for TBIO - Telesis Bio, Inc.

Grade Last Price % Change Price Change
F 1.31 -65.80% -2.52
TBIO closed up 18.58 percent on Monday, September 30, 2024, on 33 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Nov 11
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
20 DMA Support Bullish -65.80%
Crossed Above 50 DMA Bullish -65.80%
Outside Day Range Expansion -65.80%
Wide Bands Range Expansion -65.80%
Gapped Down Weakness -65.80%
Fell Below 50 DMA Bearish -59.44%
20 DMA Support Bullish -59.44%
Calm After Storm Range Contraction -59.44%
Wide Bands Range Expansion -59.44%
Gapped Down Weakness -59.44%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 24 hours ago
Down 5% 1 day ago
Down 3% 1 day ago
Fell Below 50 DMA 1 day ago
Fell Below Previous Day's Low 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Telesis Bio, Inc. Description

Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Molecular Biology Gene Expression Synthetic Biology Molecular Genetics Messenger RNA

Is TBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.06
52 Week Low 1.27
Average Volume 1,894,885
200-Day Moving Average 5.50
50-Day Moving Average 3.46
20-Day Moving Average 2.88
10-Day Moving Average 2.84
Average True Range 0.90
RSI (14) 55.75
ADX 37.62
+DI 44.64
-DI 16.85
Chandelier Exit (Long, 3 ATRs) 2.48
Chandelier Exit (Short, 3 ATRs) 3.96
Upper Bollinger Bands 4.81
Lower Bollinger Band 0.96
Percent B (%b) 0.75
BandWidth 133.64
MACD Line -0.03
MACD Signal Line -0.22
MACD Histogram 0.1892
Fundamentals Value
Market Cap 114.7 Million
Num Shares 29.9 Million
EPS -1.31
Price-to-Earnings (P/E) Ratio -2.92
Price-to-Sales 0.33
Price-to-Book 0.54
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.86
Resistance 3 (R3) 5.67 4.81 5.52
Resistance 2 (R2) 4.81 4.29 4.90 5.40
Resistance 1 (R1) 4.32 3.98 4.57 4.51 5.29
Pivot Point 3.46 3.46 3.58 3.55 3.46
Support 1 (S1) 2.97 2.94 3.22 3.16 2.37
Support 2 (S2) 2.11 2.63 2.20 2.26
Support 3 (S3) 1.62 2.11 2.14
Support 4 (S4) 1.81